Elevance Health SEC filings, summarized
We read every Elevance Health 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.
Track ELV in your inbox
Add Elevance Health to your watchlist — free, every morning.
Recent filings
Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit…
Elevance Health ($ELV) reaffirms FY2026 adjusted shareholders’ earnings ≥ $25.50/share and 2026 benefit expense ratio 90.2% ±50 bps; officers to speak with…
Feb 27, 2026: CMS notified Elevance Health ($ELV) of intent to impose intermediate sanctions — suspend…
Feb 27, 2026: CMS notified Elevance Health ($ELV) of intent to impose intermediate sanctions — suspend MA‑PD enrollment and certain beneficiary…
Elevance Health ($ELV) filed an 8‑K on Feb 26, 2026 furnishing a press release (Exhibit 99.1) and the…
Elevance Health ($ELV) filed an 8‑K on Feb 26, 2026 furnishing a press release (Exhibit 99.1) and the embedded Interactive XBRL cover page (Exhibit 104).…
Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net…
Elevance Health ($ELV) reaffirms FY2026 EPS guidance: ≥ $22.30 diluted (includes ~ $3.20 of net unfavorable items); adjusted EPS excluding those items ≥…
Elevance Health ($ELV) announced Feb 26, 2026 that Peter D.
Elevance Health ($ELV) announced Feb 26, 2026 that Peter D. Haytaian will transition from EVP & President of Carelon effective May 4, 2026 to devote more…
Elevance Health ($ELV) filed an 8‑K on Jan 28, 2026 furnishing a press release (Exhibit 99.1) with…
Elevance Health ($ELV) filed an 8‑K on Jan 28, 2026 furnishing a press release (Exhibit 99.1) with financial results for the quarter ended Dec 31, 2025;…
Elevance Health ($ELV) on Jan 28, 2026 issued a press release reporting Q4 & full‑year 2025 financial…
Elevance Health ($ELV) on Jan 28, 2026 issued a press release reporting Q4 & full‑year 2025 financial results; the release is furnished as Exhibit 99.1. 📢…